GETTING MY MBL77 TO WORK

Deep, qualified future-technology sequencing has discovered that subclonal mutations (i.e., All those current in only a fraction of tumor cells) may be detected for all driver genes and therefore are associated with fast illness progression and lousy outcome.11–13 This is especially appropriate for TP53 mutations provided the fact that, as stated